Average Co-Inventor Count = 7.61
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (7 from 2,405 patents)
2. Sirna Therapeutics, Inc. (5 from 138 patents)
3. Sloan-kettering Institute for Cancer Research (2 from 512 patents)
4. Merck + Co., Inc. (1 from 4,770 patents)
5. Sima Therapeutics, Inc. (1 from 5 patents)
16 patents:
1. 11117917 - Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
2. 10221205 - Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
3. 10214742 - Tetragalnac containing conjugates and methods for delivery of oligonucleotides
4. 9840531 - Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
5. 9655976 - Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
6. 9540639 - Tetragalnac containing conjugates and methods for delivery of oligonucleotides
7. 9428492 - Secondary alcohol substituted triazoles as PDE10 inhibitors
8. 9200001 - Triazolyl PDE10 inhibitors
9. 9062059 - Pyrimidine PDE10 inhibitors
10. 8993779 - Positive allosteric modulators of MGLUR2
11. 8975286 - Ether benzotriazole derivatives
12. 8785481 - Ether benzotriazole derivatives
13. 8765784 - Positive allosteric modulators of MGLUR2
14. 7645454 - Prostate specific antigens and uses thereof
15. 7531181 - Gp120 specific antigens and uses thereof